Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Operating Expenses (2016 - 2026)

Orthofix Medical has reported Operating Expenses over the past 17 years, most recently at $150.2 million for Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses fell 1.65% year-over-year to $150.2 million, compared with a TTM value of $617.7 million through Mar 2026, up 86.34%, and an annual FY2025 reading of $620.2 million, up 0.75% over the prior year.
  • Operating Expenses came in at $150.2 million for Q1 2026, down from $152.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $440.2 million in Q4 2023 to a low of $9.5 million in Q3 2023.
  • Median Operating Expenses over the past 5 years was $150.2 million (2026), compared with a mean of $118.3 million.
  • The sharpest move saw Operating Expenses tumbled 69.46% in 2023, then soared 1396.2% in 2025.
  • Over 5 years, Operating Expenses stood at $267.4 million in 2022, then skyrocketed by 64.61% to $440.2 million in 2023, then crashed by 64.43% to $156.6 million in 2024, then dropped by 2.86% to $152.1 million in 2025, then fell by 1.25% to $150.2 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Operating Expenses are $150.2 million (Q1 2026), $152.1 million (Q4 2025), and $162.9 million (Q3 2025).